Preview

The BRICS Health Journal

Advanced search

National priorities for strengthening health systems in the BRICS countries: the cases of Brazil, China and Russia

https://doi.org/10.47093/3034-4700.2026.3.1.3-18

Contents

Scroll to:

Abstract

The objective of this article is to present selected examples of priority policies recently implemented in the health systems of Brazil, China, and Russia. In Brazil, two major initiatives are mentioned: the Family Health Strategy, which reorganizes Primary Health Care through territorially defined multidisciplinary teams responsible for delivering comprehensive, community-based services; and the Popular Pharmacy Program of Brazil, which expands access to essential medicines, thereby strengthening financial protection and promoting equity within the Unified Health System. In China, reforms are guided by the Healthy China 2030 strategy, a comprehensive national agenda aimed at improving the general health of the population, reinforcing preventive approaches, modernizing service delivery, and advancing digital health innovation. Emphasis is placed on tuberculosis control policies that integrate patient-centred care with coordinated public health actions, enhancing continuity of care and treatment outcomes. In Russia, priority initiatives include policies designed to support ageing populations, strengthen primary care and preventive services. In doing this, they aim to maximize patient satisfaction as a system-level performance indicator within the framework of Mandatory Health Insurance. The dissemination of these priority policies within the BRICS framework may facilitate the exchange of policy experiences, technical expertise, and institutional innovations, thereby contributing to South—South cooperation in health. The BRICS Network of Research in Public Health and Health Systems represents a promising platform for advancing collaborative research and promoting such benchmarking initiatives.

For citations:


Hoirisch C., Pereira A.M., Kobyakova O.S., Shevchenko M.A., Cui Y., Wang X., Chen H., Huang F., Hu J., Lai Ch., Wang Yu., Liu K., Machado C.V. National priorities for strengthening health systems in the BRICS countries: the cases of Brazil, China and Russia. The BRICS Health Journal. 2026;3(1):3-18. https://doi.org/10.47093/3034-4700.2026.3.1.3-18

Introduction

At their first BRICS Health Ministers meeting in 2011 in Beijing, China, the group acknowledged several shared public health challenges, including unequal access to healthcare and medicines, rising healthcare costs, infectious diseases such as human immunodeficiency virus (HIV) and tuberculosis (TB), and increasing rates of chronic non-communicable diseases1. At that time, their primary challenge was to provide healthcare to millions of people, particularly the most vulnerable population groups.

Since then, the same challenges have persisted. BRICS countries face various public health threats caused by shifts in lifestyle behaviors, environmental conditions, disease patterns, and population demographics. These include non-communicable diseases such as obesity, diabetes, cardiovascular diseases, cancer, and mental health issues [1], which are increasing in many nations, as well as ongoing infectious diseases like TB, HIV / acquired immunodeficiency syndrome (AIDS), and respiratory illnesses. Other major threats include diarrheal diseases, neglected tropical diseases common in many BRICS countries, and emerging infectious diseases, as seen with outbreaks like SARS in China (2002–2003) [2]; recurrent dengue (2000–2024) [3], and Zika (2015–2016) [4] in Brazil. These challenges are not exclusive to the Global South, as the COVID-19 pandemic has shown. Diseases do not respect borders.

Global health faced significant disruptions in 2025. Changes took place in the landscape of international health cooperation: the United States administration decided to withdraw from the World Health Organization (WHO)2; suspended its contributions to international health organizations such as Gavi, the Vaccine Alliance3; and restricted data-sharing between the US Centers for Disease Control and Prevention (CDC) and WHO4. Additionally, substantial cuts were made to American funding for biomedical research [5][6], to name but a few. These developments significantly undermined global health funding, forcing many countries to reallocate resources domestically and look for alternative solutions to address emerging challenges.

In this complex setting, BRICS countries see this as an opportunity to leverage their health expertise and experience in South—South cooperation as a means to engage in global health diplomacy. One example is the BRICS Network of Research in Public Health and Health Systems, established jointly under the presidencies of Russia and Brazil (2024–2025) [7]. The objective of this Network is to generate evidence to strengthen health systems through shared research, capacity building, and technical cooperation. At its second meeting, held on May 29, 2025, the Network invited its members to share examples of priority policies within their respective health systems. The aim was to encourage the exchange of experiences among BRICS countries and to promote technical cooperation between two or more member states.

The aim of this review is to present selected examples of priority policies recently implemented in Brazil, China, and Russia to strengthen public health systems and expand access to healthcare. This analysis aims to contribute to international technical cooperation in health among countries facing similar challenges. The documents used are from official government sources, and the bibliographic references cited were obtained from databases such as PubMed, SciELO, Springer Nature and the authors’ own archives.

Brazilian unified health system: strengthening primary health care and access to medicines

National priorities in healthcare include major public health programs such as the Family Health Strategy (Estratégia de Saúde da Família, ESF), the Popular Pharmacy Program of Brazil (Programa Farmácia Popular do Brasil, PFPB), the National Immunization Program, and well-known initiatives for HIV/AIDS control, organ transplantation, hepatitis C treatment, and tobacco control, among others5. Below are details on two exemplary programs: the ESF and the PFPB.

The Family Health Strategy

The Family Health Program, later renamed the ESF, was launched in 1994 to expand and organize primary health care (PHC) nationwide. The strategy initially relied on multiprofessional teams that included at least a physician, a nurse, a nurse technician, and Community Health Agents (Agente Comunitário de Saúde, ACS) – key players in connecting health teams with communities and supporting public health efforts within local territories. Later, oral health and other specialized healthcare professionals were added to support the core teams. The ESF places health at the centre of the individual’s, families’, and community’s needs and plays a crucial role in restructuring PHC in Brazil, fully aligned with the guiding principles of Unified Health System (Sistema Único de Saúde, SUS). The strategy has contributed to the expansion, improvement, and strengthening of PHC, transforming work processes with significant potential to enhance the quality of care. Besides increasing service effectiveness and leading to positive health outcomes for individuals and communities, ESF also stands out for its efficiency and excellent cost-effectiveness in the public health sector [8].

Designed to address Brazil’s diverse and unique health needs, ESF operates through multidisciplinary teams adapted to territorial, cultural, and social specificities. These teams develop health actions based on detailed knowledge of local realities and population needs. Different team configurations may be adopted, depending on the setting. They work together in an integrated and complementary way, expanding access, equity, and quality of care. The ESF model aims to strengthen connections and proximity between health units, users, and their families, thereby enhancing access and continuity of care [9].

The key objectives and guidelines of the ESF include expanding PHC coverage; contributing to the regulation and management of care flows; fostering community mobilization and participation; promoting bonds and population follow-up; encouraging good practices and continuous monitoring; ensuring comprehensive health care for enrolled populations; and increasing access to health services [8][9].

Over the past 31 years, the Strategy has achieved the following: 54,742 Family Health Teams (equipes de Saúde da Família, eSF) currently active in the country’s Basic Health Units (Unidades Básicas de Saúde, UBS), serving the population; 990,120 PHC professionals; 103,042 teams co-funded by the Ministry of Health (MoH) 26,756 doctors participating in the More Doctors Program; and a federal budget allocation of R$ 54.9 billion in 2024).

The eSF is the core unit of PHC. It is responsible for creating individual, family, and community health actions that include health promotion, prevention, protection, diagnosis, treatment, rehabilitation, harm reduction, palliative care, and health surveillance – delivered through coordinated care practices and skilled management. Each team serves a specific geographic area and is responsible for the health of that population6.

These teams serve as the main entry point for the population into the health system, aiming to provide continuous care within their communities. They identify and address the factors and determinants behind the most common health conditions and needs. In doing so, they bring health care closer to the social and daily realities of the people they serve.

Key activities performed by eSF include both individual and group interventions – such as medical visits, vaccinations, procedures, home visits, group activities, and other initiatives that promote comprehensive care. These actions take place in UBS, in people’s homes, and in community spaces like schools and associations, based on local health needs and following national priorities and guideline7.

Federal funding is crucial in shaping and influencing health policy, with significant potential to reorganize the health care model [10]. Currently, there are 277,341 ACS, along with 54,742 eSF teams financed by the MoH8. The minimum composition required to implement an eSF includes a doctor, nurse, nursing assistant and/or technician, and ACS. Additional federal resources may be available if PHC includes other health professionals, such as dentists, psychologists, physiotherapists, and nutritionists9.

The implementation of the ESF was associated with relevant effects on the reduction of infant and under-5 mortality, especially in the postnatal period and for infectious diseases, and on mortality and hospitalizations for the general population and specific age groups, with emphasis on preventable causes by PHC actions and services, although the association of ESF with reduction in hospitalizations and some causes of mortality in the adult population has not been observed in some studies [11] During the COVID-19 pandemic, areas with high ESF coverage recorded lower mortality rates compared to low-coverage areas [12]. Regions with stronger primary care networks also carried out more home visits and health promotion activities, underscoring the vital role of primary care in Brazil’s effective pandemic response and recovery.

Pharmaceutical care in Brazilian unified health system: the Popular Pharmacy Program of Brazil

During the 20th century, the first public pharmaceutical care initiatives in Brazil aimed to ensure medicines availability through programs targeting specific infectious diseases [13]. In the 1970s and 1980s, efforts to boost domestic production intensified, and a national List of Essential Medicines was established to ensure access of basic medicines in public health facilities [14].

Since the 1990s, within the scope of SUS, pharmaceutical care policies have been broadened and diversified. Programs were established to supply basic medicines (for PHC), strategic medicines (to manage specific diseases like HIV/AIDS and TB), and specialized medicines (for rare or costly diseases, including cancers). Policies were introduced to encourage the use of generic medicines and to regulate the incorporation of medicines into the SUS. However, limitations remained, including high out-of-pocket medication expenses [15].

In the 2000s, additional strategies were implemented to increase the national production of medicines and other health supplies. In 2004, the country launched the PFPB to address the urgent need for all citizens – regardless of their financial situation – to access essential medicines for treating both chronic and acute illnesses within PHC [15]. From the beginning, the program was integrated into the National Pharmaceutical Care Policy, which goes beyond just dispensing medicines and is based on the principles of the SUS10.

As of February 14, 2025, the PFPB started offering all listed medicines and supplies free of charge to the Brazilian population through partnerships with private pharmacies11. Previously, access depended on a co-payment system where the government covered 90% of the medicine’s reference price, and individuals paid the remaining amount, which varied based on the pharmacy’s prices and the official reference value.

The program currently covers 12 medical conditions and provides 41 types of medicines used to treat hypertension, diabetes mellitus and diabetes mellitus associated with cardiovascular diseases, asthma, osteoporosis, high cholesterol, rhinitis, Parkinson’s disease, and glaucoma, as well as contraceptives, sanitary pads, and geriatric diapers for people with incontinence12.

The program has played a key role in advancing Brazil’s public policy for access to medicines. In 2012, the WHO recognized it as a successful model for expanding access to essential drugs13. It has also been consistently rated among the most well-regarded social programs in the country, with approval from more than 80% of Brazilians, according to data from the MoH.

In 2024, the program served 24 million people14. It is currently available in 4,823 municipalities, covering 86% of Brazilian cities and reaching approximately 97% of the population through a network of more than 31,000 accredited pharmacies15.

The PFPB has enabled patients to continue treatment without interruption. The program has been associated with reductions in hospital admissions for conditions such as diabetes, hypertension, as well as a decrease in mortality from circulatory diseases. Its positive effects have increased with age, being most significant among older adults [16].

The program has eased the financial burden on families. It also increased the use of generic medicines from 51% in January 2011 to 85% in 2024 of the medicines dispensed under the Aqui Tem Farmácia Popular initiative16. Regarding diabetes medications, the PFPB accounted for 70% of generic sales between 2005 and 2011 [17]. This expansion stimulated the national pharmaceutical industry, generating positive effects within Brazil’s Health Economic-Industrial Complex [18]. Estimates indicate that the program’s benefits – such as reduced hospitalization costs and lives saved – outweigh its implementation costs [19].

China’s health system: priority policies and strategic directions

Strategic framework and primary pare development

China’s priority health policies in recent years have centred on strengthening universal health coverage, advancing PHC, deepening public hospital reform, and accelerating digital transformation. The Healthy China 2030 strategy provides the overarching framework, emphasising disease prevention, health promotion, and intersectoral governance. Strengthening primary care has been a persistent policy focus, reflected in the expansion of family-doctor contracting services, chronic disease management programmes, and the development of regional integrated delivery networks, particularly medical consortia (yi-lian-ti) linking tertiary hospitals with county hospitals and township health centres [20].

Public hospital reform remains central to China’s health system transformation. The Sanming Model introduced integrated governance restructuring, centralized drug procurement, and strict cost controls, providing a template for national reforms [21]. A core component is the Three Medical Linkage (san-yi-lian-dong) reform, which aligns medical services, medical insurance, and pharmaceutical policy to correct distorted provider incentives and address the legacy of financing care through drug-markups [22]. Since 2017, this approach has strengthened National Healthcare Security Administration’s role as a strategic purchaser, unified price-setting for services, advanced centralized procurement of medicines and consumables, and expanded Diagnosis-Related Group / Diagnosis-Intervention Packet (DRG/DIP) payment reforms. Together, these measures aim to enhance clinical appropriateness, improve efficiency, and enhance transparency and accountability across the public-hospital sector. In parallel, digital health has accelerated, supported by the National Health Information Platform, cross-provincial electronic health records [23], telemedicine networks serving rural and remote areas, and the integration of artificial intelligence into diagnostics and population surveillance [24].

Disease prevention, control and integrated service delivery

Aligning with the WHO’s Multisectoral Accountability Framework for TB (MAF-TB), China’s TB control practices focus on integrating patient-centered care with strong government commitment, supported by health insurance and coordinated systems [25]. China has established robust policies to integrate TB services into health insurance to reduce catastrophic costs, and subsidies for impoverished patients. A collaborative network was established to link CDC, designated TB hospitals, and PHC for seamless continuum of care from screening through treatment completion. To improve case detection, China has implemented mass screening among high-risk groups (e.g., students, the elderly, and the poor) and general populations in high-prevalence areas. This effort, underpinned by multi-departmental coordination, ensures universal access to health care. The strategy emphasizes protecting vulnerable populations, enabling early diagnosis and drug resistance screening, and delivering standardized treatment coupled with rigorous health management [25].

In 2024, China launched several national campaigns to address service gaps in key public-health domains. The Year of Pediatric and Mental Health Services aims to expand availability, accessibility, and quality of pediatric and mental-health care. By 2027, the initiative seeks to ensure that most common childhood illnesses can be treated at the municipal or county level, that major pediatric diseases receive timely care within regional centres, and that continuity and convenience of pediatric services are substantially enhanced. Mental-health reforms require psychiatric hospitals and large general hospitals to establish psychological and sleep clinics, while clinicians across specialties are encouraged to integrate routine mental-health assessment into clinical practice. Public education campaigns are being institutionalized to raise awareness of common psychological problems, reduce stigma, and promote earlier care-seeking17.

At the same time, China initiated the nationwide Weight Management Year as part of the Healthy China (2019–2030) Action Plan. Recognising overweight and obesity as major risk factors for cardiovascular disease, diabetes, and certain cancers, the initiative focuses on strengthening health literacy, improving access to supportive environments for healthy lifestyles, and fostering behavioural change. From 2024, the campaign aims – within approximately three years – to build a comprehensive social foundation for weight management, improve national awareness and practical skills in diet and physical activity, and reduce the prevalence of abnormal weight patterns among key population groups [26].

Systemic challenges and future directions

Collectively, these policies – spanning financing reform, digital health, integrated service delivery, child and mental health services, and healthy lifestyle promotion – reflect China’s shift toward a prevention-oriented, people-centred, and system-wide approach to population health.

Despite long-term progress in expanding coverage, strengthening service capacity, and improving financial protection, China’s health system continues to face substantial structural pressures [24]. Non-communicable diseases now constitute the dominant burden of morbidity and mortality, with cardiovascular disease, cancer, chronic obstructive pulmonary disease, and diabetes shaped by rapid population ageing, behavioural risks, and environmental exposures [27]. Although major infectious diseases are generally well controlled, conditions such as tuberculosis, HIV, and hepatitis B still require sustained public-health attention [28]. Persistent inequalities across regions, income groups, and between urban and rural areas reflect the uneven distribution of high-quality medical resources and ongoing shortages in primary care and support services for the elderly, particularly affecting internal migrant populations. Systemic challenges – characterized by a predominant reliance on hospital-based care, developing gatekeeping mechanisms, heterogeneity in service standards, and insufficient integration between clinical care and public health – continue to constrain performance [29]. Rising costs associated with advanced technologies, pharmaceuticals, and long-term care further underscore the need for stronger primary care, improved coordination mechanisms, and long-term workforce development [26][30].

Russia’s health system: strategic directions in Russia’s healthcare policy

Russia follows a strategic agenda focused on improving the quality of life and longevity, developing human potential, and ensuring technological independence. This strategy is aligned with national priorities mandated by the President of the Russian Federation18 [31]. To achieve these goals, the nation relies on many national projects, which include federal initiatives detailing precise methods, tools, and measurable outcomes.

One prominent national project was Healthcare, implemented from 2019 to 2024. Besides aiming to boost life expectancy, it addressed the following key objectives: decreasing overall mortality rates, infant mortality, resolving staff shortages in PHC facilities, providing universal preventive medical screenings, improve access to PHC, simplifying doctor appointment bookings, and expanding exports of medical services19.

The national project comprised nine federal initiatives: the export of medical services, diabetes control (from 2023 onwards), modernizing PHC delivery, pediatric healthcare and modern childcare infrastructure, building up national medical research center networks and introducing innovative medical technologies, recruiting qualified healthcare staff, oncology care, cardiovascular diseases control, and unified digital ecosystem in healthcare anchored by the Unified State Information System in Healthcare20 [32].

Under the umbrella of the national project Healthcare (2019–2024), progress was reported, including in reduced infant mortality rates, greater uptake of preventive medical checkups, extensive involvement of specialists in continuing professional development, and growth in medical service exports. Additional highlights include construction and renovation of over 10,000 medical facilities, procurement of 230,000 medical devices, preventive health checks for 109 million individuals in 2024 and 1.5 million fee-free high-tech surgical interventions21.

Maternal and child health included expanding neonatal screening to cover 40 pathologies and opening 21 new hospitals. More than 2,500 clinics were upgraded during the years 2019–2024, and in 2024, 58,000 children with diabetes received free continuous glucose monitoring systems. Support for medical professionals was another focal point, with over 12,000 newly trained specialists joining the workforce in 2023–2024. Additionally, 450,000 rural healthcare workers received augmented social benefits in 2024, while more than one million medical employees now enjoy supplementary salary incentives22.

An equally significant national endeavor was the Demography project, spanning 2019–2024. Like Healthcare, its primary national goal centered on raising life expectancy. Its core objectives involved elevating healthy-life expectancy, uplifting birth rates, and advocating healthier lifestyle choices and encouraging regular physical exercise among citizens. It incorporated several federal initiatives such as Financial Aid for New Parents, Assisting Women’s Reentry Into the Job Market – Establishing Early Learning Opportunities for Children Up to Age Three, Designing and Implementing a Plan for Systematically Supporting Seniors and Enhancing Their Quality of Life, Fostering Positive Habits Around Diet and Fitness, Curbing Harmful Practices, and Enabling Broad Participation in Sport Activities Nationwide, Increasing Accessibility of Sports Venues, and Cultivating Future Athletic Talent Reserves23 [33].

By the end of 2023, the Demography project led to the establishment of 83 regional geriatric centres, exceeding the initial target of 80, delivery of care to 211,300 senior citizens through geriatric wards, an increase in the percentage of citizens participating in regular physical activity and sports, reaching 56.8%24.

Holistic approach to combating non-communicable diseases

In addition to national projects, Russia adopts specific practices aimed at addressing systemic healthcare challenges. Notably, efforts to combat non-communicable diseases follow a holistic approach involving multi-sectoral strategies, including launching mass-screening programs, reducing excessive salt and sugar intake, promoting physical activity, restricting tobacco and alcohol consumption. This approach also shows that prevention of non-communicable diseases cannot be done by the health sector only. It needs joint actions in public-health regulation, food policy, education, local communities and workplaces, because many risk factors are connected not only with personal choice, but also with everyday environment [34][35].

Tobacco control legislation

Curtailing smoking – one of the foremost causes of non-communicable diseases and premature death – is especially prioritized. In 2013, Federal Law No. 15-FZ introduced rigorous anti-smoking measures which were subsequently expanded to cover nicotine-containing products25. These measures include a ban on smoking tobacco or using nicotine-containing products in public places, including healthcare, educational and residential facilities; service establishments; sports and fitness venues; retail premises; all forms of public transport; children’s playgrounds; elevators, etc. They also include price and tax measures to reduce demand; regulation of product composition, disclosure, packaging and labelling; ban on advertising, sponsorship and sales promotion; restrictions on the retail trade, including point-of-sale displays and merchandising. Also, enforcement measures to combat illicit trade in tobacco products and nicotine-containing items and a ban on the sale of tobacco products, nicotine goods, hookahs and vaping devices to minors, and a prohibition on their use by minors or any involvement of children in tobacco or nicotine consumption. Public information campaigns also highlight the health dangers of tobacco and nicotine use and of exposure to second-hand smoke and aerosol emissions [36][37].

These legislative measures have been effective. Tobacco consumption has declined by 23% over the past five years, with behavioural habits shifting decisively away from smoking. Since 2009, the number of adult smokers (aged 15+) has dramatically declined, dropping from 39.5% in 2009 to just 18.6% in 202426.

Supporting ageing populations and developing geriatrics

Demographic shifts have prompted integrated geriatric-care models. Multidisciplinary hospitals now host geriatric offices that assess fall, delirium and frailty risks, develop individual care plans and reduce polypharmacy thus enhancing the functional independence of older patients. Federal support covers geriatric training, primary-care integration and clear referral pathways [38].

Alongside clinical care, a healthy lifestyle is promoted among older adults through free programmes delivered under the Active Longevity initiative, which is linked to Russia’s new national project Family. These programs include therapeutic exercise classes; Nordic walking and other sports activities; creative clubs and community events; and educational courses27.

Together, these measures support functional independence and quality of life. These programs now cover millions of older citizens nationwide. Participants pursue self-development and help others discover new interests. The responsible authorities are the Ministry of Health of the Russian Federation and the Ministry of Labor and Social Protection of the Russian Federation28.

Strengthening primary care and prevention

The federal project Development of the Primary Health-Care System was designed to remove territorial and infrastructure barriers to medical services. Between 2019 and 2024, more than 10,000 medical facilities were built or renovated, and 230,000 pieces of medical equipment were procured. In 2024, 109 million people underwent preventive examinations, and 1.5 million high-tech procedures were provided free of charge29.

In parallel, new outpatient care models are being introduced, including optimized patient pathways, shorter waiting times and better coordination among facilities, digital-health tools and continuous federal monitoring through so-called “initiatives” (targeted pilot projects addressing specific bottlenecks). For example, Initiative No. 38 – launched in September 2022 – aims to make online appointments as easy as possible30, while Initiative No. 7 – launched in 2023 – focuses on introducing electronic sanitary medical certificates, as evidenced by a sustained rise in public satisfaction with service quality31.

Through the Healthcare project (and from 2025 the new Long and Active Life project) Russia has expanded preventive follow-ups and screenings, improved rural access, through feldsher-midwife stations and rolled out telemedicine and digital health tools. More than 6.7 million people aged 18–49 underwent reproductive health screening; more than 96 percent of newborns received expanded neonatal screening; 74.7 percent of citizens underwent preventive exams; and 112.4 million people were informed about prevention options32,33 [39].

Patient satisfaction as a system priority

Research shows that higher patient satisfaction is associated with better treatment adherence, improved clinical outcomes, fewer complaints and greater trust in the healthcare system34. Accordingly, patient-experience metrics are embedded in national targets, specifically as targets in the federal project Modernisation of Primary Health Care under National Healthcare Project.

Building on the methodological guidelines and the Patient Satisfaction Survey approved by MoH Order No. 495 (19 July 2022) “On Approving the Methodology for Calculating the Additional Indicator ‘Public Opinion Assessment of Satisfaction with Medical Care, %” Russian Research Institute of Health has developed and rolled out the STIMUL (СТИМУЛ) Management Standard – an organisation-wide framework specifically designed to raise patient satisfaction levels [31]. The STIMUL management standard, focuses on communication quality, service comfort/accessibility and rapid feedback response. In several regions, the standard has been scaled up to the level of the constituent entity, enabling uniform, region-wide approaches to managing the patient experience.

Obtained results include deploying the STIMUL management standard in over 40 regions. In healthcare facilities where the Standard was implemented, patient complaints halved within three years. Patient satisfaction increased and was associated with better adherence and reduced unnecessary hospital visits, better accessibility due to streamlined processes. Overall, national patient satisfaction scores reportedly increased 1.4-fold over a two-year period35.

Digitalisation and data-driven decision-making

The rapid expansion of the Unified State Health Information System has become a cornerstone of health-system governance at every level [40]. Thanks to real-time dashboards, artificial-intelligence tools and predictive analytics, regional authorities can now forecast trends, assess risks and apply truly personalised population-health management [41].

One striking success is the creation of dedicated situation centres [42]. These hubs integrate digital dashboards with AI-driven decision-support, enabling health administrators to monitor key indicators, spot emerging issues early and deploy resources proactively. These situation centres enhance inter-regional coordination, transparency and rapid public-health response.

Conclusion

This article examines a few select priority policies implemented in the health systems of Brazil, China, and Russia, highlighting national strategies aimed at strengthening public health systems and expanding access to health services. Despite differences in institutional design, financing and governance, the experiences discussed reveal shared commitments to equity, system resilience, and state leadership in health system development.

In Brazil, priority policies have focused on reinforcing the SUS by expanding access to comprehensive PHC and specialized care, strengthen regionalized networks, and improve coordination across levels of care. These policies reflect long-standing efforts to address territorial inequalities and ensure universal access in a highly decentralized system.

China’s experience highlights system integration, stronger PHC, and digital transformation. Priority policies have combined large-scale public investments with governance reforms aimed at increasing efficiency, expanding coverage, and improving service quality. Digital health tools and data-driven management has played a key role in enhancing access and continuity of care.

In Russia, priority health policies are integrated into nationally coordinated programs, characterized by strong federal leadership, clear strategic planning, and long-term public investment. National initiatives focusing on healthcare modernization, demographic changes, and population health have prioritized infrastructure improvements, technological modernization, and workforce capacity.

Across the three countries, common challenges emerge, including demographic transitions, growing demand for specialized and long-term care, health workforce shortages, and the need to strengthen PHC as the foundation of resilient health systems. At the same time, these shared challenges create opportunities for cooperation among BRICS countries.

Cooperation within the BRICS framework can facilitate the exchange of policy experiences, technical knowledge, and institutional innovations, particularly in health system governance, digital health, workforce training, and strategies to reduce regional inequalities. The BRICS Network of Research in Public Health and Health Systems represents a promising platform for comparative research, capacity building, and joint initiatives tailored to the realities of middle-income countries with large and diverse populations.

By fostering structured dialogue and technical cooperation, BRICS countries can contribute to mutual learning and the broader global health agenda, offering alternative pathways for strengthening public health systems grounded in equity, solidarity, and state responsibility. The experiences discussed in this article underscore the relevance of South—South cooperation in addressing shared health system challenges and advancing universal health coverage and access.

1. BRICS Health Ministers Declaration. Accessed 19.05.2026. http://brics.br/pt-br/documentos/acervo-de-presidencias-anteriores/health-ministerial-declarations/2011-brics-health-ministers-declaration.pdf

2. Withdrawing the United States from the World Health Organization. Accessed 19.05.2026. https://www.whitehouse.gov/presidential-actions/2025/01/withdrawing-the-united-states-from-the-worldhealth-organization/

3. U.S. to end vaccine funds for poor countries. Accessed 19.05.2026. https://www.nytimes.com/2025/03/26/health/usaid-cuts-gavi-bird-flu.html

4. CDC ordered to stop working with WHO immediately, upending expectations of an extended withdrawal. Accessed 19.05.2026. https://apnews.com/article/cdc-who-trump-548cf18b1c409c7d22e17311ccdfe1f6

5. Ministério da Saúde. Ações e programas [Ministry of Health. Actions and programs] (in Portuguese). Accessed 19.05.2026. https://www.gov.br/saude/pt-br/acesso-a-informacao/acoes-e-programas

6. Brazil, 2017. Ministério da Saúde. Portaria no 2.436, de 21 de setembro de 2017. Aprova a política nacional de atenção básica, estabelecendo a revisão de diretrizes para a organização da atenção básica, no âmbito do sistema único de saúde (SUS) [Brazil, 2017. Ministry of Health. Ordinance No. 2,436 of September 21, 2017. Approves the National Primary Health Care Policy, establishing a revision of guidelines for the organization of primary health care within the scope of the Unified Health System (SUS)] (in Portuguese). Accessed 19.05.2026. https://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt2436_22_09_2017.html

7. Ibid.

8. Política Nacional da Atenção Básica. Equidade, vínculo e qualidade no cuidado. Estratégia Saúde da Família [National Primary Health Care Policy. Equity, bonding, and quality in care. Family Health Strategy] (in Portuguese). Accessed 19.05.2026. https://congresso.cosemspr.org.br/wp-content/uploads/2025/12/Politica-Nacional-da-Atencao-Basica.pdf

9. Ministério da Saúde [Ministry of Health] (in Portuguese). Accessed 19.05.2026. https://www.gov.br/saude/pt-br/composicao/saps/esf/equipe-saude-da-familia

10. Brazil, n.d.Ministério da Saúde. Programa Farmácia Popular [Brazil, n.d. Ministry of Health. Popular Pharmacy Program] (in Portuguese). 19.05.2026. https://www.gov.br/saude/pt-br/composicao/sectics/farmacia-popular

11. Ibid.

12. Brazil, 2025. Elenco de medicamentos e insumos [Brazil, 2025. List of medicines and supplies] (in Portuguese). Accessed 19.05.2026. https://www.gov.br/saude/pt-br/composicao/sectics/farmacia-popular/arquivos/elenco-de-medicamentos-e-insumos.pdf

13. The pursuit of responsible use of medicines: sharing and learning from country experiences. Accessed 19.05.2026. https://iris.who.int/server/api/core/bitstreams/c7a583ee-b3d1-4c7e-bd1b-181047d6802f/content

14. Brazil, 2025. Farmácia Popular beneficiou mais de 24 milhões de brasileiros em 2024, maior número da série histórica [Brazil, 2025. Farmácia Popular benefited more than 24 million Brazilians in 2024, the highest figure in the historical series] (in Portuguese). Accessed 19.05.2026. https://agenciagov.ebc.com.br/noticias/202502/farmacia-popular-beneficiou-mais-de-24-milhoes-de-brasileiros-em-2024-maior-numero-da-serie-historica

15. Brazil, 2025. Ministério da Saúde. Farmácia Popular amplia atendimento e chega a mais de 400 novos municipio [Brazil, 2025. Ministry of Health. Farmácia Popular expands service and reaches over 400 new municipalities] (in Portuguese). 19.05.2026. https://www.gov.br/saude/pt-br/assuntos/noticias/2025/janeiro/farmacia-popular-amplia-atendimento-e-chega-a-mais-de-400-novos-municipios

16. CFF, 2025. Medicamentos genéricos completam 26 anos e reforçam acesso à saúde no Brasil [CFF, 2025. Generic medicines mark 26 years and boost access to healthcare in Brazil] (in Portuguese). Accessed 19.05.2026. https://site.cff.org.br/noticia/Noticias-gerais/04/02/2025/medicamentos-genericos-completam-26-anos-e-reforcam-acesso-a-saude-no-brasil

17. State Council of the People’s Republic of China. China to expand pediatric, mental health services. Accessed 19.05.2026. https://english.www.gov.cn/news/202501/02/content_WS6775c85dc6d0868f4e8ee6e9.html

18. Указ Президента Российской Федерации от 07.05.2024 г. № 309 «О национальных целях развития Российской Федерации на период до 2030 года и на перспективу до 2036 года» [Decree of the President of the Russian Federation No. 309 of May 7, 2024 “On the National Development Goals of the Russian Federation for the Period up to 2030 and for the Perspective Up to 2036] (in Russian). Accessed 19.05.2026. http://www.kremlin.ru/acts/bank/50542

19. Паспорт национального проекта «Здравоохранение» [Passport of the national project “Healthcare”] (in Russian). Accessed 19.05.2026. http://static.government.ru/media/files/gWYJ4OsAhPOweWaJk1prKDEpregEcduI.pdf

20. Ibid.

21. Annual Government report on its performance to the State Duma, 26 March 2025. Accessed 19.05.2026. http://government.ru/en/news/54597/

22. Ibid.

23. Паспорт национального проекта «Демография» [Passport of the national project “Demography”] (in Russian). Accessed 19.05.2026. http://static.government.ru/media/files/Z4OMjDgCaeohKWaA0psu6lCekd3hwx2m.pdf

24. Татьяна Голикова обсудила с регионами реализацию нацпроекта «Демография» [Tatyana Golikova discussed with the regions the implementation of the national project “Demography”] (in Russian). Accessed 19.05.2026. http://government.ru/news/51453/

25. Федеральный закон от 23.02.2013 г. № 15-ФЗ «Об охране здоровья граждан от воздействия окружающего табачного дыма и последствий потребления табака» [Federal Law No. 15-FZ of February 23, 2013 “On the protection of citizens’ health from the effects of second-hand tobacco smoke, the consequences of tobacco consumption or the consumption of nicotine-containing products”] (in Russian). Accessed 19.05.2026. http://government.ru/docs/all/100633/

26. ЕМИСС. Государственная статистика [EMISS. Official statistics] (in Russian). Accessed 19.05.2026. https://www.fedstat.ru/indicator/62581

27. Министерство труда и социальной защиты. С начала 2025 года охват программами активного долголетия увеличился на 400 тысяч человек [Ministry of Labor and Social Protection of the Russian Federation. Since the beginning of 2025, the coverage of active ageing programs has increased by 400 thousand people] (in Russian). Accessed 19.05.2026. https://mintrud.gov.ru/social/social/1358

28. Ibid.

29. Annual Government report on its performance to the State Duma. Accessed 19.05.2026. http://government.ru/en/news/54597/

30. Приказ Росздравнадзора от 21.11.2024 № 6598 «Об утверждении Программы профилактики рисков причинения вреда (ущерба) охраняемым законом ценностям при осуществлении федерального государственного контроля (надзора) качества и безопасности медицинской деятельности в 2025 году» [Order of Roszdravnadzor No. 6598 dated November 21, 2024, “On Approval of the Program for the Prevention of Risks of Harm (Damage) to Legally Protected Values During the Exercise of Federal State Control (Supervision) over the Quality and Safety of Medical Activities in 2025”] (in Russian). Accessed 19.05.2026. https://roszdravnadzor.gov.ru/spec/control/preventive/documents/85656

31. Отраслевой инцидент № 7 (электронные медицинские документы) [Industry Initiative No. 7 (electronic medical documents)] (in Russian). Accessed 19.05.2026. https://depzdrav.yanao.ru/activity/47596/

32. Министерство транспорта Российской Федерации. Почти 7 млн россиян проверили репродуктивное здоровье по полису ОМС [Ministry of Transport of the Russian Federation. Nearly 7 million Russians have had their reproductive health checked under their compulsory medical insurance policy]. (in Russian). Accessed 19.05.2026. https://mintrans.gov.ru/press-center/branch-news/6734

33. Министерство здравоохранения Российской Федерации. Информация о реализации федерального проекта «Развитие системы оказания первичной медико-санитарной помощи» национального проекта «Здравоохранение» за период 2019–2024 годов [Ministry of Health of the Russian Federation. Information on the implementation of the federal project “Development of the Primary Health Care System” of the national project “Healthcare” for the period 2019–2024] (in Russian). Accessed 19.05.2026. https://minzdrav.gov.ru/special/ministry/natsproektzdravoohranenie/pervichka

34. Ibid.

35. Unpublished data. Data from the monitoring of the indicator “Population satisfaction with medical care based on the results of public opinion assessment”, federal project “Modernization of primary health care in the Russian Federation”, national project “Long and active life”.

References

1. Burki TK. BRICS nations tackle non-communicable diseases. Lancet Oncol. 2012;13(5):451. doi:10.1016/S1470-2045(12)70151-1

2. Knobler S, Institute of Medicine (U.S.), Institute of Medicine (U.S.), eds. Learning from SARS: Preparing for the next Disease Outbreak: Workshop Summary. National Academies Press; 2004.

3. Gurgel-Gonçalves R, Oliveira WKD, Croda J. The greatest Dengue epidemic in Brazil: Surveillance, Prevention, and Control. Rev Soc Bras Med Trop. 2024;57:e00203-2024. doi:10.1590/0037-8682-0113-2024

4. Ladhani SN, O’Connor C, Kirkbride H, Brooks T, Morgan D. Outbreak of Zika virus disease in the Americas and the association with microcephaly, congenital malformations and Guillain – Barré syndrome. Arch Dis Child. 2016;101(7):600-602. doi:10.1136/archdischild-2016-310590

5. Garisto D, Kozlov M. US Supreme Court allows NIH to cut $2 billion in research grants. Nature. 2025;645(8079):18-19. doi:10.1038/d41586-025-02721-5

6. Collier R. Massive cuts to science and medicine in Trump budget. Can Med Assoc J. 2017;189(23):E812-E813. doi:10.1503/cmaj.1095437

7. Hoirisch C, Pereira AMM, Estephanio JM, et al. BRICS leaders issue Rio de Janeiro Declaration and highlight health initiatives led by Fiocruz. BRICS Health J. 2025;2(3):15-26. doi:10.47093/3034-4700.2025.2.3.15-26

8. Barros RDD, Aquino R, Souza LEPF. Evolução da estrutura e resultados da Atenção Primária à Saúde no Brasil entre 2008 e 2019 [Evolution of the structure and results of Primary Health Care in Brazil between 2008 and 2019]. (In Portuguese). Ciênc Saúde Coletiva. 2022;27(11):4289-4301. doi:10.1590/1413-812320222711.02272022

9. Castro DMD, Oliveira VBD, Andrade ACDS, Cherchiglia ML, Santos ADFD. Impacto da qualidade da atenção primária à saúde na redução das internações por condições sensíveis [Impact of primary health care quality on the reduction of hospitalizations for ambulatory care-sensitive conditions]. (In Portuguese). Cad Saúde Pública. 2020;36(11):e00209819. doi:10.1590/0102-311x00209819

10. Mendes Á, Carnut L, Guerra LDDS. Reflexões acerca do financiamento federal da Atenção Básica no Sistema Único de Saúde [Reflections on federal funding for Primary Health Care within the Unified Health System]. (In Portuguese). Saúde Em Debate. 2018;42(spe1):224-243. doi:10.1590/0103-11042018s115

11. Aquino R, Vilasbôas ALQ. Impacts of the Family Health Strategy on the health status of the Brazilian population: a literature review. Cienc Saude Coletiva. 2025;30(12):e13942025. doi:10.1590/1413-812320253012.13942025

12. Teixeira AD, Postali FAS, Ferreira-Batista NN, Diaz MDM, Moreno-Serra R. The role of primary healthcare amid the COVID-19 pandemic: evidence from the family health strategy in Brazil. Soc Sci Med. 2024;359:117221. doi:10.1016/j.socscimed.2024.117221

13. Ribeiro MA. Saúde pública e as empresas químico-farmacêuticas [Public health and chemical-pharmaceutical companies]. (In Portuguese). Hist Cienc Saude-Manguinhos. 2000;7(3):607-626.

14. Figueiredo TA, Fialho Neto RG, Magalhães JLD. The public production of medicines in Brazil. Ciênc Saúde Coletiva. 2021;26(suppl 2):3423-3434. doi:10.1590/1413-81232021269.2.31962019

15. Luiza VL, Oliveira MA, Chaves GC, Flynn MB, Bermudez JAZ. Pharmaceutical Policy in Brazil. In: Babar ZUD, ed. Pharmaceutical Policy in Countries with Developing Healthcare Systems. Springer International Publishing; 2017:123-149. doi:10.1007/978-3-319-51673-8_7

16. Almeida ATCD, Sá EBD, Vieira FS, Benevides RPDSE. Impacts of a Brazilian pharmaceutical program on the health of chronic patients. Rev Saúde Pública. 2019;53:20. doi:10.11606/S1518-8787.2019053000733

17. Alencar TDOS, Araújo PS, Costa EA, Barros RD, Lima YOR, Paim JS. Programa Farmácia Popular do Brasil: uma análise política de sua origem, seus desdobramentos e inflexões [Farmácia Popular do Brasil Program: a political analysis of its origins, developments, and shifts in direction]. (In Portuguese). Saúde Em Debate. 2018;42(spe2):159-172. doi:10.1590/0103-11042018s211

18. Gadelha CAG, Gimenez DM, Cajueiro JPDM, Moreira JDD. O Econômico-Industrial da Saúde (CEIS) como espaço estratégico para a modernização do SUS e para a geração dos empregos do futuro [Complexo Health Economic-Industrial Complex (CEIS) as a strategic space for the modernization of the SUS and for the generation of jobs of the future]. (In Portuguese). Ciênc Saúde Coletiva. 2023;28(10):2833-2843. doi:10.1590/1413-812320232810.10672023

19. Ferreira PAA. Efeitos do copagamento de medicamentos sobre a saúde no Brasil: evidências do programa Aqui Tem Farmácia Popular [Effects of medications copayment on the Brazilian health system: evidences of the Aqui Tem Farmácia Popular program]. (In Portuguese). Revista do BNDES. 2017;47:67-117. Accessed 19.05.2026. https://web.bndes.gov.br/bib/jspui/bitstream/1408/14019/1/Efeitos%20do%20copagamento%20de%20medicamentos%20sobre%20a%20sa%C3%BAde%20no%20Brasil..._P_BD.pdf

20. Li X, Krumholz HM, Yip W, et al. Quality of primary health care in China: challenges and recommendations. The Lancet. 2020;395(10239):1802-1812. doi:10.1016/S0140-6736(20)30122-7

21. McCall C. The Sanming model: reforming China’s health system. The Lancet. 2025;405(10496):2193-2194. doi:10.1016/S0140-6736(25)01285-1

22. Liu T, Shen J, Zhang X, et al. A scoping review of Chinese national policies to promote the three-medicals linkage reform since 2014. Npj Health Syst. 2025;2(1):9. doi:10.1038/s44401-025-00012-9

23. Tao W, Gu T, Li Y, Li W. Electronic health card: a technological solution to promote the Chinese integrated healthcare system in the digital age. BMJ Health Care Inform. 2023;30(1):e100911. doi:10.1136/bmjhci-2023-100911

24. Yip W, Fu H, Chen AT, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. The Lancet. 2019;394(10204):1192-1204. doi:10.1016/S0140-6736(19)32136-1

25. Long Q, Jiang WX, Zhang H, Cheng J, Tang SL, Wang WB. Multi-source financing for tuberculosis treatment in China: key issues and challenges. Infect Dis Poverty. 2021;10(1):17. doi:10.1186/s40249-021-00809-4

26. Sun X, Sun Z, Peng W, et al. Expert Consensus and call on actions for weight management in China: advancing Healthy China Initiative through strategic actions. China CDC Wkly. 2024;6(51):1347-1353. doi:10.46234/ccdcw2024.268

27. Force LM, Kocarnik JM, May ML, et al. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet. 2025;406(10512):1565-1586. doi:10.1016/S0140-6736(25)01635-6

28. Su B, Talifu Z, Feng L, et al. Epidemiological shifts in infectious diseases in China: implications and policy recommendations. China CDC Wkly. 2023;5(42):948-951. doi:10.46234/ccdcw2023.178

29. Tao W, Zeng Z, Dang H, et al. Towards universal health coverage: lessons from 10 years of healthcare reform in China. BMJ Glob Health. 2020;5(3):e002086. doi:10.1136/bmjgh-2019-002086

30. The Lancet. Health progress in a post-COVID-19 world. The Lancet. 2025;406(10513):1701. doi:10.1016/S0140-6736(25)01947-6

31. Tyufilin DS, Shibalkov IP, Vyskochkov VS, Shelegova DA, Deev IA, Kobyakova OS. Pазработка и апробация стандарта системы управления медицинской организацией, направленной на повышение удовлетворенности пациентов медицинской помощью [Development and testing of a standard for a medical organization management system aimed at increasing patient satisfaction]. (In Russian). Social Aspects of Population Health. 2023;4:1106-1128. doi:10.24412/2312-2935-2023-4-1106-1128

32. Murashko MA. Modern healthcare model in the Russian Federation. BRICS Health J. 2026;2(4):3-16. doi:10.47093/3034-4700.2025.2.4.3-16

33. Kondakova NA, Budilov AP, Korolenko AV. Анализ реализации национального проекта «Демография» в России [Analysis of the implementation of the national project “Demography”]. (In Russian). Journal of Management Studies. 2019;5(5):48–55. Accessed 19.05.2026. https://naukaru.ru/en/nauka/article/33556/view

34. Sheiman I, Shishkin S, Sazhina S. Vertical program of screenings and check-ups in the Russian Federation: design, implementation and lessons learnt. Arch Public Health. 2022;80(1):123. doi:10.1186/s13690-022-00878-3

35. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. Профилактика хронических неинфекционных заболеваний в Российской Федерации. Национальное руководство 2022 [2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines]. (In Russian). Cardiovasc Ther Prev. 2022;21(4):3235. doi:10.15829/1728-8800-2022-3235

36. Gambaryan MG, Drapkina OM. Эффективность реализации антитабачных законодательных мер в отношении распространенности курения в 10 субъектах Российской Федерации с 2013 по 2018 г. [Impact of implementation of Tobacco control legislative measures on smoking prevalence in 10 Russian Federal Subjects from 2013 to 2018]. (In Russian). Profil Meditsina. 2021;24(2):44. doi:10.17116/profmed20212402144

37. Skvortsova EL, Morozova IA. Обзор законодательного регулирования производства и оборота электронных систем доставки никотина и предложения по актуализации технического регулирования [Overview of the legislative regulation of the production and circulation of electronic nicotine delivery systems and a proposal for updating technical regulation]. (In Russian). Toxicol Rev. 2023;31(2):72-82. doi:10.47470/0869-7922-2023-31-2-72-82

38. Sharashkina NV, Tkacheva ON, Runikhina NK, et al. Комплексная гериатрическая оценка – основной инструмент работы врача-гериатра [Comprehensive geriatric assessment – the main tool for the work of a geriatrician]. (In Russian). Russ J Geriatr Med. 2023;(4):210-227. doi:10.37586/2686-8636-4-2022-210-227

39. Voronin SV, Zakharova EYu, et al. Расширенный неонатальный скрининг на наследственные заболевания в России: первые итоги и перспективы [Advanced neonatal screening for hereditary diseases in Russia: first results and future prospects]. (In Russian). Pediatr J Named GN Speransky. 2024;103(1):16-29. doi:10.24110/0031-403X-2024-103-1-16-29

40. Gusev AV, Vladzimirskii AV, Golubev NA, Zarubina TV. Информатизация здравоохранения Российской Федерации: история и результаты развития [Informatization of healthcare in the Russian Federation: history and results of development]. (In Russian). Natl Health Care Russ. 2022;2(3):5-17. doi:10.47093/2713-069X.2021.2.3.5-17

41. Murashko MA, Vankov VV, Panin AI, et al. Внедрение технологий искусственного интеллекта в здравоохранении России: итоги 2024 г. [Implementation of artificial intelligence technologies in healthcare in Russia: results of 2024]. (In Russian). Natl Health Care Russ. 2025;6(3):6-19. doi:10.47093/2713-069X.2025.6.3.6-19

42. Vankov VV, Artemova OR, Gusev AV. Digital transformation of healthcare in the Russian Federation. BRICS Health J. 2024;1(1):20-34. doi:10.47093/3034-4700.2024.1.1.20-34.


About the Authors

Claudia Hoirisch
Oswaldo Cruz Foundation
Brazil

Claudia Hoirisch, Master’s in administration with a focus on health policies, Researcher, Vice- President, Global Health and International Relations, Coordinator, BRICS Network of Research in Public Health and Health Systems in Brazil, Vice-President, Global Health and International Relations, Fiocruz

4.365, Brasil Ave., Rio de Janeiro, 21040-900, Brazil

 



Adelyne Maria Mendes Pereira
Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation
Brazil

Adelyne Maria Mendes Pereira, PhD (Public health), Postdoctoral researcher (Global health), Researcher, Department of Health Administration and Planning, Accredited Professor, Public Health Graduate Program, Coordinator, BRICS Network of Research in Public Health and Health Systems in Brazil, Sergio Arouca National School of Public Health, Fiocruz

1.480, Rua Leopoldo Bulhões, Rio de Janeiro, 21041-210, Brazil



Olga S. Kobyakova
Russian Research Institute of Health of the Ministry of Health of the Russian Federation
Russian Federation

Olga S. Kobyakova, MD, DSc (Medicine), Professor, Corresponding Member of the Russian Academy of Sciences, Director, Russian Research Institute of Health of the Ministry of Health of the Russian Federation

11, Dobrolyubova str., Moscow, 127254, Russia



M. A. Shevchenko
Russian Research Institute of Health of the Ministry of Health of the Russian Federation
Russian Federation

Maria A. Shevchenko, MBA, Head of International Relations Department, Deputy Head of the International Center for Strengthening National Health Systems, Coordinator, BRICS Network of Research in Public Health and Health Systems in Russia, Russian Research Institute of Health of the Ministry of Health of the Russian Federation

11, Dobrolyubova str., Moscow, 127254, Russia



Ying Cui
Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)
China

Ying Cui, PhD (Public health), Director, Office of Policy Planning and Research, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)

155, Changbai Road, Changping District, Beijing, 102206, China



Xiaoqi Wang
Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)
China

Xiaoqi Wang, MSc (Medicine), Director, Office of International Cooperation, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Member of the UN Consultative Committee on Life Science and Human Health (CCLH), China Association for Science and Technology

155, Changbai Road, Changping District, Beijing, 102206, China



Hao Chen
Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)
Russian Federation

Hao Chen, MPH, Deputy Director, Office of Policy Planning and Research, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)

155, Changbai Road, Changping District, Beijing, 102206, China



Fei Huang
Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)
China

Fei Huang, Director, Applied technology department of National Center for TB control and prevention, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Deputy Secretary, General of Chinese Anti-Tuberculosis Association

155, Changbai Road, Changping District, Beijing, 102206, China



Jingran Hu
Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)
China

Jingran Hu, MPH, MA, Associate Researcher, Office of International Cooperation, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)

155, Changbai Road, Changping District, Beijing, 102206, China



Chengyu Lai
Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)
China

Chengyu Lai, LLM, Assistant Researcher, Office of Policy Planning and Research, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)

155, Changbai Road, Changping District, Beijing, 102206, China



Yuan Wang
Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)
China

Yuan Wang, MPH, Associate Researcher, Office of Policy Planning and Research, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)

155, Changbai Road, Changping District, Beijing, 102206, China



Kaixuan Liu
Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)
China

Kaixuan Liu, MPH, Assistant Researcher, Office of Policy Research, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)

155, Changbai Road, Changping District, Beijing, 102206, China



Cristiani Vieira Machado
Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation
Brazil

Cristiani Vieira Machado, PhD (Public health), Professor, Researcher, Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation – Ensp/Fiocruz

1480, Rua Leopoldo Bulhões, 21040-900, Brazil



Review

For citations:


Hoirisch C., Pereira A.M., Kobyakova O.S., Shevchenko M.A., Cui Y., Wang X., Chen H., Huang F., Hu J., Lai Ch., Wang Yu., Liu K., Machado C.V. National priorities for strengthening health systems in the BRICS countries: the cases of Brazil, China and Russia. The BRICS Health Journal. 2026;3(1):3-18. https://doi.org/10.47093/3034-4700.2026.3.1.3-18

Views: 474

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3034-4700 (Print)
ISSN 3034-4719 (Online)